EyePoint Pharmaceuticals Inc’s filing revealed that its Director Zaderej Karen L. acquired Company’s shares for reported $29950.0 on May 19
EyePoint Pharmaceuticals Inc’s recent filing unveils that its Director Zaderej Karen L. acquired Company’s shares for reported $29950.0 on May
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, EyePoint Pharmaceuticals Inc revealed its Director Zaderej Karen L. acquired Company’s shares for reported $29950.0 on May
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. EyePoint Pharmaceuticals
EyePoint Pharmaceuticals Inc’s recent filing unveils that its Director Zaderej Karen L. acquired Company’s shares for reported $29950.0 on May
EyePoint Pharmaceuticals Inc’s recently made public that its Director Zaderej Karen L. acquired Company’s shares for reported $29950.0 on May